|

SGT-212 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Solid Biosciences Inc.1

Indications

  • Friedreich's Ataxia (FA)1
  • Heart Disease1

Los Angeles, California1 trial

A Study of SGT-212 Gene Therapy in Friedreich's Ataxia

The University of California, Los Angeles (UCLA)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.